Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (5): 816-821. doi: 10.19723/j.issn.1671-167X.2018.05.009

• Article • Previous Articles     Next Articles

Transurethral flexible ureteroscopic holmium laser resection for tumors of renal pelvis: 6 cases report and literature review

HAO Yi-chang1*, CHEN Kun2*, LIU Yu-qing1, LU Jian1, XIAO Chun-lei1△, MA Lu-lin1△   

  1. (1. Department of Urology, Peking University Third Hospital, Beijing 100191, China; 2. Department of Urology, People’s Hospital of Zhengzhou, Zhengzhou 450003, China)
  • Online:2018-10-18 Published:2018-10-18
  • Contact: XIAO Chun-lei, MA Lu-lin E-mail: xiaochunleixcl@sina.com, malulin@medmail.com.cn

Abstract: Objective: To summarize the experience of flexible ureteroscopic holmium laser resection in treatment of renal pelvic carcinoma and to evaluate its value in treatment of renal pelvic carcinoma. Methods: The clinical data of 6 patients with renal pelvic carcinoma treated in Peking University Third Hospital from January 2015 to January 2017 were retrospectively analyzed. The 6 patients were treated by the same experienced urologist and by flexible ureteroscopic holmium laser resection of renal pelvic tumors under general anesthesia. Regarding the intensity of the holmium laser, 10-30 W was generally used with settings of 0.5-1.5 J and 10-20 Hz. In general, a 200 μm end-firing holmium laser fiber was used. Narrow-band imaging (NBI) technique was applicated to search for tumors and check whether the excision was satisfactory. Routine “second flexible ureteroscopy” was performed after 4-6 weeks, and suspected lesions were referred for a biopy, then vaporized and cauterized. The ureteroscopy was examined every 6 months after operation, and color Doppler ultrasound, computed tomography urography (CTU) or magnetic resonance urography (MRU) were performed at the same time. The urine tumor cells were examined for 3 days before the operation, and the urine tumor markers, such as urinary nuclear matrix protein 22 (NMP22) were tested. For cases with high-risk urothelial carcinoma and normal renal function, and 6 cycles of systemic adjuvant chemotherapy were performed after operation. Results: All of the cases were successfully treated. The data were as follows: the operation time 77.5 min (45-115 min), the blood loss 10 mL (5-20 mL), and hospital stay after surgery 3 days (2-5 days). After 13-34 months’ follow-up, two patients had recurrent tumor recurrence and underwent resection operation. Two patients received systemic adjuvant chemotherapy after operation. Case 5 was histopathologically high grade urothelial carcinoma, and 6 cycles of systemic chemotherapy were given after operation. Local recurrence occurred during chemotherapy, and then endoscopic operation was performed, and no recurrence occurred in the follow-up for 12 months after reoperation. In case 6, the pathology was low grade urothelial carcinoma, but the case was multiple tumors in the right renal calyx and the lower calyx. Then 6 cycles of systemic chemotherapy were given, and no recurrence was found in the follow-up for 13 months. Conclusion: Transurethral flexible ureteroscopic holmium laser resection is relatively safe for the treatment of renal pelvic carcinoma. It is suitable for special cases of solitary kidney and renal dysfunction, as well as for patients with low risk urinary tract epithelial tumors, but the recurrence rate is high, and the indications need to be strictly controlled. Patients with high-risk urothelial carcinoma who underwent endoscopic resection are advised to receive systemic adjuvant gemcitabine and cisplatin (GC) regimen after surgery, in order to increase the overall survival rate. Systemic chemotherapy combined with endoscopic operation may become a new treatment for upper tract urothelial carcinoma (UTUC).

Key words: Ureteroscopy, Holmium laser, Renal pelvic carcinoma

CLC Number: 

  • R737.11
[1] Lei WANG,Tian-dong HAN,Wei-xing JIANG,Jun LI,Dao-xin ZHANG,Ye TIAN. Comparison of safety and effectiveness of active migration technique and in situ lithotripsy technique in the treatment of 1-2 cm upper ureteral calculi by flexible ure-teroscopy [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 553-557.
[2] Ke LIU,Fan ZHANG,Chun-lei XIAO,Hai-zhui XIA,Yi-chang HAO,Hai BI,Lei ZHAO,Yu-qing LIU,Jian LU,Lu-lin MA. Low power seven-step two-lobe holmium laser enucleation of the prostate technique for surgical treatment of benign prostatic hyperplasia [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1159-1164.
[3] Run-zhuo MA,Hai-zhui XIA,Min LU,Zhi-ying ZHANG,Qi-ming ZHANG,Jian LU,Guo-liang WANG,Lu-lin MA. Impact of diagnostic ureteroscopy and biopsy on radical nephroureterectomy of upper tract urothelial carcinoma [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 665-672.
[4] MA Run-zhuo, QIU Min, HE Wei, YANG Bin, XIA Hai-zhui, ZOU Da, LU Min, MA Lu-lin1, LU Jian. Ureteroscope can assist risk stratification in upper tract urothelial carcinoma [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 632-637.
[5] MA Kai, HUANG Xiao-Bo, XIONG Liu-Lin, XU Qing-Quan, XU Tao, YE Hai-Yun, YU Lu-Ping, WANG Xiao-Feng. Treatment of upper urinary calculi through novel modular flexible ureteroscope: a report of 36 cases [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 615-617.
[6] ZHANG Li-Jie, YE Xiong-Jun, HUANG Xiao-Bo, XIONG Liu-Lin, MA Kai, LI Jian-Xing, WANG Xiao-Feng. Comparison of tubeless-percutaneous nephrolithotomy and ureteroscopic lithotripsy in treatment of upper-ureteral calculi sized ≥1.5 cm [J]. Journal of Peking University(Health Sciences), 2015, 47(1): 170-174.
[7] YANG Bo, HU Wei-Guo, HU Hao, CHEN Liang, LI Jian-Xing, WANG Xiao-Feng. Causes and remediations of retrograde intrarenal surgery failure in renal calculi treatment [J]. Journal of Peking University(Health Sciences), 2014, 46(5): 794-797.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!